{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T08:07:04Z","timestamp":1772006824747,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd002219","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,8,15]],"date-time":"2012-08-15T00:00:00Z","timestamp":1344988800000}}],"reference-count":58,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd002219.pub2","type":"journal-article","created":{"date-parts":[[2012,8,8]],"date-time":"2012-08-08T15:24:09Z","timestamp":1344439449000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Ivermectin for onchocercal eye disease (river blindness)"],"prefix":"10.1002","volume":"2012","author":[{"given":"Henry OD","family":"Ejere","sequence":"first","affiliation":[{"name":"Hode Internal Medicine; 125 South Park Drive, Suite F Brownwood Texas USA 76801"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Institute of Ophthalmology; 11 - 43 Bath Street London UK EC1V 9EL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Wormald","sequence":"additional","affiliation":[{"name":"London School of Hygiene & Tropical Medicine; Cochrane Eyes and Vision Group, ICEH; Keppel Street London UK WC1E 7HT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer R","family":"Evans","sequence":"additional","affiliation":[{"name":"London School of Hygiene & Tropical Medicine; Cochrane Eyes and Vision Group, ICEH; Keppel Street London UK WC1E 7HT"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,8,15]]},"reference":[{"issue":"8838","key":"10.1002\/14651858.CD002219.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0140-6736(93)90002-X","article-title":"Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis","volume":"341","author":"Abiose","year":"1993","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD002219.pub2-BIB0002|cit2","first-page":"229","article-title":"Impact of annual dosing with ivermectin on progression of onchocercal visual field loss","volume":"75","author":"Cousens","year":"1997","journal-title":"Bulletin of the World Health Organization"},{"issue":"3","key":"10.1002\/14651858.CD002219.pub2-BIB0003|cit3","first-page":"355","article-title":"Ophthalmological results from a placebo controlled comparative 3-dose ivermectin study in the treatment of onchocerciasis","volume":"40","author":"Dadzie","year":"1989","journal-title":"Tropical Medicine and Parasitology"},{"issue":"8","key":"10.1002\/14651858.CD002219.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/bjo.72.8.561","article-title":"Effect of single-dose ivermectin therapy on human onchocerca volvulus infection with onchocercal ocular involvement","volume":"72","author":"Newland","year":"1988","journal-title":"British Journal of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD002219.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"494","DOI":"10.4269\/ajtmh.1989.40.494","article-title":"Ivermectin treatment of patients with severe ocular onchocerciasis","volume":"40","author":"Taylor","year":"1989","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"3","key":"10.1002\/14651858.CD002219.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/infdis\/156.3.463","article-title":"Controlled trial and dose-finding study of ivermectin for treatment of onchocerciasis","volume":"156","author":"White","year":"1987","journal-title":"Journal of Infectious Diseases"},{"issue":"8775","key":"10.1002\/14651858.CD002219.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/0140-6736(91)91963-U","article-title":"Effects of repeated doses of ivermectin on ocular onchocerciasis: community-based trial in Sierra Leone","volume":"338","author":"Whitworth","year":"1991","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD002219.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0035-9203(91)90236-R","article-title":"A community trial of ivermectin for onchocerciasis in Sierra Leone: adverse reactions after the first five treatment rounds","volume":"85","author":"Whitworth","year":"1991","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"3","key":"10.1002\/14651858.CD002219.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0035-9203(92)90308-Y","article-title":"A community trial of ivermectin for onchocerciasis in Sierra Leone: clinical and parasitological responses to four doses given at six-monthly intervals","volume":"86","author":"Whitworth","year":"1992","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD002219.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0140-6736(88)90022-0","article-title":"Community-based treatment with ivermectin","volume":"ii","author":"Whitworth","year":"1988","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD002219.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.trstmh.2004.04.003","article-title":"A randomized, double-blind, controlled trial of the effects of ivermectin at normal and high doses, given annually or three-monthly, against Onchocerca volvulus: ophthalmological results","volume":"99","author":"Fobi","year":"2005","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"9328","key":"10.1002\/14651858.CD002219.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(02)09456-4","article-title":"Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial","volume":"360","author":"Gardon","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD002219.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/bjo.78.1.8","article-title":"The distribution and aetiology of blindness and visual impairment in mesoendemic onchocercal communities in Kaduna State, Nigeria","volume":"78","author":"Abiose","year":"1994","journal-title":"British Journal of Ophthalmology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD002219.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1080\/00034983.1998.11813361","article-title":"Onchocercal eye disease and the impact of Mectizan treatment","volume":"92","author":"Abiose","year":"1998","journal-title":"Annals of Tropical Medicine and Parasitology"},{"issue":"9240","key":"10.1002\/14651858.CD002219.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0140-6736(05)73271-2","article-title":"Onchocerciasis control strategies","volume":"356","author":"Abiose","year":"2000","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD002219.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0277-9536(99)00336-6","article-title":"Community-perceived benefits of ivermectin treatment in north-eastern Nigeria","volume":"50","author":"Akogun","year":"2000","journal-title":"Society for Science in Medicine"},{"issue":"8291","key":"10.1002\/14651858.CD002219.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(82)91026-1","article-title":"Efficacy and tolerance of ivermectin in human onchocerciasis","volume":"2","author":"Aziz","year":"1982","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD002219.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/bjo.64.3.191","article-title":"Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate","volume":"64","author":"Bird","year":"1980","journal-title":"British Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD002219.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4269\/ajtmh.1998.58.461","article-title":"Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis","volume":"58","author":"Boussinesq","year":"1998","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"9112","key":"10.1002\/14651858.CD002219.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(97)12450-3","article-title":"Onchocerciasis","volume":"351","author":"Burnham","year":"1998","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD002219.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0035-9203(92)90310-9","article-title":"Adverse events following mass ivermectin therapy for onchocerciasis","volume":"86","author":"Chijioke","year":"1992","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"4","key":"10.1002\/14651858.CD002219.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1076\/opep.6.4.229.4185","article-title":"Effect of repeated ivermectin treatments on ocular onchocerciasis: evaluation after six to eight dosings","volume":"6","author":"Chippaux","year":"1999","journal-title":"Ophthalmic Epidemiology"},{"issue":"9","key":"10.1002\/14651858.CD002219.pub2-BIB0023|cit23","first-page":"1717","article-title":"Absence of cellular responses to a putative autoantigen in onchocercal chorioretinopathy. Cellular autoimmunity in onchocercal chorioretinopathy","volume":"37","author":"Cooper","year":"1996","journal-title":"Investigative and Ophthalmological Visual Science"},{"key":"10.1002\/14651858.CD002219.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0169-4758(97)01005-3","article-title":"The pathogenesis of chorioretinal disease in onchocerciasis","volume":"13","author":"Cooper","year":"1997","journal-title":"Parasitology Today"},{"issue":"6","key":"10.1002\/14651858.CD002219.pub2-BIB0025|cit25","first-page":"707","article-title":"Adverse reactions after large-scale treatment of onchocerciasis with ivermectin: combined results from eight community trials","volume":"67","author":"De-Sole","year":"1989","journal-title":"Bulletin of the World Health Organization"},{"issue":"7","key":"10.1002\/14651858.CD002219.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"e497","DOI":"10.1371\/journal.pntd.0000497","article-title":"Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal","volume":"3","author":"Diawara","year":"2009","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"9070","key":"10.1002\/14651858.CD002219.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0140-6736(96)11094-1","article-title":"Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection","volume":"350","author":"Gardon","year":"1997","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD002219.pub2-BIB0028|cit28","first-page":"130","article-title":"How to identify randomized controlled trials in MEDLINE: ten years on","volume":"94","author":"Glanville","year":"2006","journal-title":"Journal of the Medical Library Association"},{"issue":"4","key":"10.1002\/14651858.CD002219.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2165\/00003495-199142040-00007","article-title":"Ivermectin: A review of its anti-filarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis","volume":"42","author":"Goa","year":"1991","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD002219.pub2-BIB0030|cit30","unstructured":"Higgins JPT Green S Assessment of study quality. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]; Section 6 The Cochrane Library, Issue 3, 2005. Chichester, UK: John Wiley & Sons, Ltd"},{"key":"10.1002\/14651858.CD002219.pub2-BIB0031|cit31","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated September 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD002219.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4049\/jimmunol.178.2.1068","article-title":"Innate immune responses to endosymbiotic Wolbachia bacteria in Brugia malayi and Onchocerca volvulus are dependent on TLR2, TLR6, MyD88, and Mal, but not TLR4, TRIF, or TRAM","volume":"178","author":"Hise","year":"2007","journal-title":"Journal of Immunology"},{"issue":"9266","key":"10.1002\/14651858.CD002219.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(00)04581-5","article-title":"Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment","volume":"357","author":"Hoerauf","year":"2001","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD002219.pub2-BIB0034|cit34","unstructured":"ISRCTN95189962 Evaluation of the impact of large scale, community directed delivery of doxycycline for the treatment of onchocerciasis: the Anti-Wolbachia (A-WOL) trial www.controlled-trials.com\/ISRCTN95189962\/"},{"key":"10.1002\/14651858.CD002219.pub2-BIB0035|cit35","volume-title":"The Epidemiology of Eye Disease","author":"Johnson","year":"1998"},{"issue":"1","key":"10.1002\/14651858.CD002219.pub2-BIB0036|cit36","first-page":"45","article-title":"Anticancer agents suppressive for adult parasites of filariasis in Mongolian jirds","volume":"224","author":"Kinnanom","year":"2000","journal-title":"Proceedings of the Society for Experimental Biological Medicine"},{"issue":"2","key":"10.1002\/14651858.CD002219.pub2-BIB0037|cit37","first-page":"141","article-title":"Visual field constriction as a cause of blindness or visual impairment","volume":"75","author":"Murdoch","year":"1997","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1002\/14651858.CD002219.pub2-BIB0038|cit38","unstructured":"NCT00790998 Study comparing moxidectin and ivermectin in subjects with Onchocerca Volvulus infection clinicaltrials.gov\/ct2\/show\/NCT00790998 (accessed 11 May 12)"},{"key":"10.1002\/14651858.CD002219.pub2-BIB0039|cit39","volume-title":"Mass Distribution of Ivermectin: A Handbook for Community Treatment of Onchocerciasis","author":"Pond","year":"1991"},{"issue":"1-2","key":"10.1002\/14651858.CD002219.pub2-BIB0040|cit40","first-page":"177","article-title":"Large scale ivermectin distribution and its epidemiological consequences","volume":"59","author":"Remme","year":"1990","journal-title":"Acta Leiden"},{"key":"10.1002\/14651858.CD002219.pub2-BIB0041|cit41","unstructured":"The Cochrane Collaboration, The Nordic Cochrane Centre Review Manager (RevMan) 2011"},{"issue":"9216","key":"10.1002\/14651858.CD002219.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0140-6736(00)02235-2","article-title":"Programmatic goals and approaches to onchocerciasis","volume":"355","author":"Richards","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD002219.pub2-BIB0043|cit43","first-page":"257","article-title":"Results of 2 eye examinations carried out with an interval of 6 years in 2 Upper Volta villages where onchocerciasis is endemic","volume":"51","author":"Rolland","year":"1974","journal-title":"Bulletin of the World Health Organization"},{"issue":"5561","key":"10.1002\/14651858.CD002219.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1126\/science.1068732","article-title":"The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness","volume":"295","author":"Saint Andre","year":"2002","journal-title":"Science"},{"issue":"9196","key":"10.1002\/14651858.CD002219.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/S0140-6736(05)77052-5","article-title":"Vision is failing for river-blindness control in Ghana","volume":"354","author":"Stevenson","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD002219.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1126\/science.2218502","article-title":"Impact of mass treatment of onchocerciasis with ivermectin on the transmission of infection","volume":"250","author":"Taylor","year":"1990","journal-title":"Science"},{"issue":"1","key":"10.1002\/14651858.CD002219.pub2-BIB0047|cit47","first-page":"10","article-title":"Filarial nematodes: a bug's life?","volume":"2","author":"Taylor","year":"2000","journal-title":"Filarial Update"},{"key":"10.1002\/14651858.CD002219.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1756-3305-5-28","article-title":"Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control","volume":"5","author":"Tekle","year":"2012","journal-title":"Parasites and Vectors"},{"issue":"2","key":"10.1002\/14651858.CD002219.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4269\/ajtmh.1990.42.148","article-title":"Effect of mass treatment of of a human population with ivermectin on transmission of Onchocerca volvulus by Simulium yahense in Liberia, West Africa","volume":"42","author":"Trpis","year":"1990","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"3","key":"10.1002\/14651858.CD002219.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/infdis\/156.3.463","article-title":"Controlled trial and dose-finding study of ivermectin for treatment of onchocerciasis","volume":"156","author":"White","year":"1987","journal-title":"Journal of Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD002219.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/sim.3008","article-title":"Allowing for uncertainty due to missing data in meta-analysis-Part 1: two-stage methods","volume":"27","author":"White","year":"2008","journal-title":"Statistics in Medicine"},{"issue":"2","key":"10.1002\/14651858.CD002219.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0035-9203(91)90037-Y","article-title":"A field study of the effect of ivermectin on intestinal helminths in man","volume":"85","author":"Whitworth","year":"1991","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"4","key":"10.1002\/14651858.CD002219.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0169-4758(92)90286-B","article-title":"Treatment of onchocerciasis with ivermectin in Sierra Leone","volume":"8","author":"Whitworth","year":"1992","journal-title":"Parasitology Today"},{"key":"10.1002\/14651858.CD002219.pub2-BIB0054|cit54","unstructured":"World Health Organization Ten years of onchocerciasis control in West Africa OCP\/GVA\/85.1B 1985"},{"key":"10.1002\/14651858.CD002219.pub2-BIB0055|cit55","unstructured":"World Health Organization Onchocerciasis (River blindness) Fact sheet No 95 Revised 2000"},{"issue":"2","key":"10.1002\/14651858.CD002219.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4103\/0974-777X.81692","article-title":"River blindness: an old disease on the brink of elimination and control","volume":"3","author":"Winthrop","year":"2011","journal-title":"Journal of Global Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD002219.pub2-BIB0057|cit57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002219","article-title":"Ivermectin for onchocercal eye disease (river blindness)","author":"Ejere","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD002219.pub2-BIB0058|cit58","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002219","article-title":"Ivermectin for onchocercal eye disease (river blindness)","author":"Ejere","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD002219.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T15:02:16Z","timestamp":1735138936000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD002219.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Eyes and Vision Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,8,15]]},"references-count":58,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2012,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002219.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,15]]}}}